Tag: dulaglutide
-
Pharmac Extends Consultation on Diabetes Medicine Access Changes, Proposing Wider Access and Removal of Ethnicity-Based Criteria
Pharmac has extended its consultation until June 11, 2026, on proposed changes to type 2 diabetes medicine access. The plan aims to widen access by lowering cardiovascular risk criteria but removes specific provisions for Māori and Pacific people.
HealthPolitics and GovernmentMedical ScienceGeneral PoliticsSocial IssuesLegal PharmacType 2 DiabetesEmpagliflozinLiraglutideDulaglutideHealth PolicyConsultationTe Pāti MāoriMaoriElection